Skip to results
Modify your search
NARROW
1-20 of 84
Authors: Hugh Calkins
Journal Article
Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial
in
EP Europace
EP Europace, Volume 27, Issue 2, February 2025, euaf007, https://doi.org/10.1093/europace/euaf007
Published: 16 January 2025
Journal Article
Clinical features and outcomes in carriers of pathogenic desmoplakin variants
European Heart Journal, Volume 46, Issue 4, 21 January 2025, Pages 362–376, https://doi.org/10.1093/eurheartj/ehae571
Published: 17 September 2024
Journal Article
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers
European Heart Journal, Volume 45, Issue 32, 21 August 2024, Pages 2968–2979, https://doi.org/10.1093/eurheartj/ehae409
Published: 16 July 2024
Journal Article
OFFICIAL STATEMENT
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation
in
EP Europace
EP Europace, Volume 26, Issue 4, April 2024, euae043, https://doi.org/10.1093/europace/euae043
Published: 08 April 2024
Journal Article
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
European Heart Journal, Volume 45, Issue 7, 14 February 2024, Pages 538–548, https://doi.org/10.1093/eurheartj/ehad799
Published: 09 January 2024
Journal Article
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
in
EP Europace
EP Europace, Volume 25, Issue 11, November 2023, euad312, https://doi.org/10.1093/europace/euad312
Published: 03 November 2023
Journal Article
From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
in
EP Europace
EP Europace, Volume 25, Issue 8, August 2023, euad180, https://doi.org/10.1093/europace/euad180
Published: 25 August 2023
Journal Article
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
European Heart Journal, Volume 43, Issue 32, 21 August 2022, Pages 3041–3052, https://doi.org/10.1093/eurheartj/ehac289
Published: 29 June 2022
Journal Article
Real world outcomes of minimally invasive epicardial surgical left atrial appendage exclusion in atrial fibrillation patients with high risk of stroke and bleeding
in
EP Europace
EP Europace, Volume 24, Issue Supplement_1, May 2022, euac053.296, https://doi.org/10.1093/europace/euac053.296
Published: 19 May 2022
Journal Article
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
European Heart Journal, Volume 43, Issue 32, 21 August 2022, Pages e1–e9, https://doi.org/10.1093/eurheartj/ehac180
Published: 18 April 2022
Journal Article
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation
European Heart Journal, Volume 43, Issue 12, 21 March 2022, Pages 1234–1247, https://doi.org/10.1093/eurheartj/ehab893
Published: 04 February 2022
Journal Article
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 363–371, https://doi.org/10.1093/ehjcvp/pvab090
Published: 27 December 2021
Journal Article
Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study
European Heart Journal, Volume 43, Issue 12, 21 March 2022, Pages 1251–1264, https://doi.org/10.1093/eurheartj/ehab772
Published: 19 November 2021
Journal Article
Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy
in
EP Europace
EP Europace, Volume 24, Issue 2, February 2022, Pages 296–305, https://doi.org/10.1093/europace/euab162
Published: 02 September 2021
Journal Article
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
in
EP Europace
EP Europace, Volume 24, Issue 2, February 2022, Pages 268–277, https://doi.org/10.1093/europace/euab183
Published: 05 August 2021
Journal Article
Spatial characterization of the tachycardia circuit of atrioventricular nodal re-entrant tachycardia
in
EP Europace
EP Europace, Volume 23, Issue 10, October 2021, Pages 1596–1602, https://doi.org/10.1093/europace/euab130
Published: 08 July 2021
Journal Article
Precision prevention with ICDs: can a simple score improve patient selection?
European Heart Journal, Volume 42, Issue 17, 1 May 2021, Pages 1685–1686, https://doi.org/10.1093/eurheartj/ehaa1102
Published: 20 January 2021
Journal Article
Radiofrequency ablation: technological trends, challenges, and opportunities
in
EP Europace
EP Europace, Volume 23, Issue 4, April 2021, Pages 511–519, https://doi.org/10.1093/europace/euaa328
Published: 30 November 2020
Journal Article
Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry
European Heart Journal, Volume 42, Issue 13, 1 April 2021, Pages 1231–1243, https://doi.org/10.1093/eurheartj/ehaa821
Published: 17 November 2020
Journal Article
Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients
in
EP Europace
EP Europace, Volume 22, Issue 8, August 2020, Pages 1270–1278, https://doi.org/10.1093/europace/euaa105
Published: 23 June 2020
